Market Overview

UPDATE: Jefferies Raises PT on CME Group Following Time with Management


In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $69.00 to $78.00.

In the report, Jefferies noted, “Last week we spent several days with the management team of CME. In addition to record volumes in the core futures business, momentum in OTC clearing is building into the June 10th mandate. While the sustainability of the “rate trade” can be debated, recent trends give a view into the potential for higher volumes in the future.”

CME Group closed on Friday at $67.93.

Latest Ratings for CME

Jan 2021OppenheimerDowngradesOutperformPerform
Jan 2021Deutsche bankDowngradesBuyHold
Jan 2021JP MorganUpgradesUnderweightNeutral

View More Analyst Ratings for CME
View the Latest Analyst Ratings


Related Articles (CME)

View Comments and Join the Discussion!

Posted-In: Daniel T. Fannon JefferiesAnalyst Color Price Target Analyst Ratings

Latest Ratings

URIVertical ResearchInitiates Coverage On310.0
PCARVertical ResearchInitiates Coverage On95.0
DEVertical ResearchInitiates Coverage On345.0
CNHIVertical ResearchInitiates Coverage On16.0
AGCOVertical ResearchInitiates Coverage On119.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at